Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $138.5 million.

  • Resmed's Other Non-Current Liabilities rose 117908.78% to $138.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $138.5 million, marking a year-over-year increase of 117908.78%. This contributed to the annual value of $141.5 million for FY2025, which is 23490.31% up from last year.
  • Per Resmed's latest filing, its Other Non-Current Liabilities stood at $138.5 million for Q4 2025, which was up 117908.78% from $138.2 million recorded in Q3 2025.
  • Resmed's 5-year Other Non-Current Liabilities high stood at $141.5 million for Q2 2025, and its period low was $10.8 million during Q4 2024.
  • In the last 5 years, Resmed's Other Non-Current Liabilities had a median value of $53.3 million in 2021 and averaged $65.8 million.
  • Per our database at Business Quant, Resmed's Other Non-Current Liabilities plummeted by 8514.14% in 2024 and then skyrocketed by 117908.78% in 2025.
  • Over the past 5 years, Resmed's Other Non-Current Liabilities (Quarter) stood at $53.2 million in 2021, then fell by 4.96% to $50.6 million in 2022, then surged by 44.05% to $72.9 million in 2023, then crashed by 85.14% to $10.8 million in 2024, then skyrocketed by 1179.09% to $138.5 million in 2025.
  • Its last three reported values are $138.5 million in Q4 2025, $138.2 million for Q3 2025, and $141.5 million during Q2 2025.